Study Name: Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
24 locations found
- GSK Investigational Site
Location: Boston, Massachusetts 02114
- GSK Investigational Site
Location: Abington, Pennsylvania 19001
- GSK Investigational Site
Location: Gainesville, Virginia 20155
- GSK Investigational Site
Location: Fairfax, Virginia 22031
- GSK Investigational Site
Location: Woodbridge, Virginia 22191
- GSK Investigational Site
Location: Augusta, Georgia 30909
- GSK Investigational Site
Location: Augusta, Georgia 30901
- GSK Investigational Site
Location: Highland Park, Illinois 60035
- GSK Investigational Site
Location: Columbia, Missouri 65201
- GSK Investigational Site
Location: Billings, Montana 59102
- GSK Investigational Site
Location: Greensboro, North Carolina 27403
- GSK Investigational Site
Location: Raleigh, North Carolina 27607
- GSK Investigational Site
Location: Abilene, Texas 79606
- GSK Investigational Site
Location: Garland, Texas 75042
- GSK Investigational Site
Location: Plano, Texas 75093
- GSK Investigational Site
Location: Murray, Utah 84157
- GSK Investigational Site
Location: Salt Lake City, Utah 84106
- GSK Investigational Site
Location: Norfolk, Virginia 23502
- GSK Investigational Site
Location: Virginia Beach, Virginia 23456
- GSK Investigational Site
Location: Chandler, Arizona 85224
- GSK Investigational Site
Location: Mesa, Arizona 85206
- GSK Investigational Site
Location: Sedona, Arizona 86336
- GSK Investigational Site
Location: Long Beach, California 90813
- GSK Investigational Site
Location: Tacoma, Washington 98405
|